Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

2011 Scrip 100: Fine-tuning the epigenetic ecosystem

This article was originally published in Scrip

Executive Summary

Ten years on and the human genome has turned out not to be quite as useful as was once hoped it might be. We didn't know that then, of course. In the deep barren void of 1990s human biology, any dim glimmer appears to bathe every question in light. What the human genome sequence and its variation among individuals demonstrated all too clearly in a Rumsfeldian manner, is that there are more ways of not knowing about human health and disease than anyone could have imagined a decade ago.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC011303

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel